Results 21 to 30 of about 554,226 (138)

Pregnancy- and parenting-related barriers to receiving medication for opioid use disorder: A multi-paneled qualitative study of women in treatment, women who terminated treatment, and the professionals who serve them [PDF]

Women's Health
Background: Women face unique barriers when seeking treatment for substance use disorders, often related to pregnancy and parenting. Objectives: This study adds to the extant literature by elucidating the pregnancy- and parenting-related barriers women ...
Hannah B. Apsley, Kristina Brant, Sarah Brothers, Eric Harrison, Emma Skogseth, Robert P. Schwartz, Abenaa Jones   +6 more
openalex   +2 more sources

Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study.

Addiction, 2020
AIM To understand the potential harmful effects of dose escalation among patients with chronic, non-cancer pain (CNCP) on chronic opioid therapy. DESIGN Retrospective cohort study.
C. Hayes, E. Krebs, T. Hudson, Joshua D. Brown, Chenghui Li, B. Martin   +5 more
semanticscholar   +1 more source

Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders

International Journal of Molecular Sciences, 2021
Nociceptin/orphanin FQ (N/OFQ) is a 17-residue neuropeptide that binds the nociceptin opioid-like receptor (NOP). N/OFQ exhibits nucleotidic and aminoacidics sequence homology with the precursors of other opioid neuropeptides but it does not activate ...
M. Ubaldi, N. Cannella, A. M. Borruto, M. Petrella, M. V. Micioni Di Bonaventura, L. Soverchia, Serena Stopponi, F. Weiss, C. Cifani, R. Ciccocioppo   +9 more
semanticscholar   +1 more source

Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States.

Epidemiologic Reviews, 2020
Prescription drug monitoring programs (PDMPs) are a crucial component of federal and state governments' response to the opioid epidemic. Evidence about the effectiveness of PDMPs in reducing prescription opioid-related adverse outcomes is mixed.
V. Puac-Polanco, Stanford T. Chihuri, David S. Fink, M. Cerdá, K. Keyes, Guohua Li   +5 more
semanticscholar   +1 more source

“You’re Not Supposed to be on it Forever”: Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids

Substance abuse : research and treatment, 2022
Opioid use disorder (OUD) through prescription opioid misuse, heroin, and illicitly manufactured fentanyl use has increased dramatically in the past 20 years.
Julia Dickson-Gomez, Antoinette L. Spector, M. Weeks, Carol L. Galletly, Madelyn McDonald, H. D. Green Montaque   +5 more
semanticscholar   +1 more source

Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.

Health & Justice, 2022
Background Jails are optimal settings in which to screen individuals for opioid use disorders (OUD) and provide needed services, especially medications for OUD (MOUD).
Christy K. Scott, C. Grella, M. Dennis, John Carnevale, Robin A LaVallee   +4 more
semanticscholar   +1 more source

A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity [PDF]

, 2005
BACKGROUND: Chronic non-cancer pain is a common problem that is often accompanied by psychiatric comorbidity and disability. The effectiveness of a multi-disciplinary pain management program was tested in a 3 month before and after trial.
A Rosenblum, AK Burton, AM Elliott, B McCarberg, B Meier, C Maier, CA Hammett-Stabler, CA Soderstrom, CD DeAngelis, CS Cleeland, CS Cleland, CS Cleland, D Bloodsworth, D Fujimoto, DA Fishbain, DA Regier, Darren A DeWalt, DC Turk, DC Turk, DE Joranson, DE Joranson, DE Moulin, DE Weissman, DG Rischitelli, DJ Kavanagh, H Flor, H Ghodse, H McQuay, J Gardner-Nix, J Porter, J Stephen Perhac, JD Bartleson, JD Clark, JE Veney, JK Iglehart, JM Harris Jr, JM Romano, JT Chibnall, JT Farrar, Katherine M Felix, KB Wells, L Allan, L Peters, L Radloff, L Webb, LH Pengel, LK Mannix, M van Tulder, Mary E Bryant, MC Reid, MC Rowbotham, ME Geisser, MF Ballesteros, MI Donovan, Michael P Pignone, MJ Bair, MJ Bair, NG Hoffmann, NJ Adams, OxyContin®, P Belluck, PA Hill, Paul R Chelminski, PE Greenberg, R Colvin, R Friedman, R Melzack, R Rothman, RA Deyo, RB Lipton, RB Lipton, RC Tait, RH Fletcher, RK Portenoy, RK Portenoy, RK Portenoy, RN Jamison, RN Jamison, Robert M Malone, RS Epstein, SA Dunbar, SD Passik, SG Gelfand, SH Roth, SM Fishman, SR Savage, SR Ytterberg, Steven D Prakken, T Bodenheimer, T Bodenheimer, T Bodenheimer, Thomas M Miller, Timothy J Ives, W Arkinstall, WF Stewart, Y Olsen   +95 more
core   +4 more sources

The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcohol use disorders: A real‐world data analysis

Addiction
Aims This study aimed to estimate the strength of association between prescriptions of glucose‐dependent insulinotropic polypeptide (GIP) and/or glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) and the incidence of opioid overdose and alcohol ...
Fares Qeadan, Ashlie McCunn, Benjamin Tingey   +2 more
openalex   +2 more sources

Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Drug and Alcohol Review, 2020
Opioid-related overdose deaths among African Americans have only recently received national attention despite evidence of increase in death rates among this population spanning the past decade.
D. Stevens-Watkins
semanticscholar   +1 more source

Chronic opioid pretreatment potentiates the sensitization of fear learning by trauma. [PDF]

, 2020
Despite the large comorbidity between PTSD and opioid use disorders, as well as the common treatment of physical injuries resulting from trauma with opioids, the ability of opioid treatments to subsequently modify PTSD-related behavior has not been well ...
Evans, Christopher J, Fanselow, Michael S, Li, Kevin, Pennington, Zachary T, Rajbhandari, Abha K, Trott, Jeremy M, Walwyn, Wendy M   +6 more
core   +1 more source